GARY GARCIA: Open Payments
NPI 1417368788 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 17 payments from 7 companies in 2025. Trend: 2023 $760 · 2024 $754 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $273 |
| ABBVIE INC. | 4 | $103 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| SPR Therapeutics, Inc | 1 | $10 |
Products named: AIRSUPRA, FARXIGA, QULIPTA, RELISTOR, UBRELVY, VRAYLAR, Kerendia, Wegovy.
Industry payments across CA — which companies pay providers there.
